CO2018007216A2 - Ensayo de cuantificacion de peptido para diferenciar quininogeno de alto peso molecular (hmwk) de longitud completa y hmwk escindido - Google Patents

Ensayo de cuantificacion de peptido para diferenciar quininogeno de alto peso molecular (hmwk) de longitud completa y hmwk escindido

Info

Publication number
CO2018007216A2
CO2018007216A2 CONC2018/0007216A CO2018007216A CO2018007216A2 CO 2018007216 A2 CO2018007216 A2 CO 2018007216A2 CO 2018007216 A CO2018007216 A CO 2018007216A CO 2018007216 A2 CO2018007216 A2 CO 2018007216A2
Authority
CO
Colombia
Prior art keywords
hmwk
molecular weight
quininogen
cleaved
length
Prior art date
Application number
CONC2018/0007216A
Other languages
English (en)
Spanish (es)
Inventor
Ryan Faucette
Jiang Wu
Guodong Zhang
Mark Szewc
Daniel J Sexton
Gul M Mustafa
Original Assignee
Dyax Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dyax Corp filed Critical Dyax Corp
Publication of CO2018007216A2 publication Critical patent/CO2018007216A2/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/72Mass spectrometers
    • G01N30/7233Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N2030/022Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027Liquid chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8831Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00Chemical aspects of mass spectrometric analysis of biological material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/22Haematology
    • G01N2800/224Haemostasis or coagulation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Enzymes And Modification Thereof (AREA)
CONC2018/0007216A 2015-12-15 2016-12-15 Ensayo de cuantificacion de peptido para diferenciar quininogeno de alto peso molecular (hmwk) de longitud completa y hmwk escindido CO2018007216A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562267734P 2015-12-15 2015-12-15
PCT/US2016/066936 WO2017106504A1 (en) 2015-12-15 2016-12-15 Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk

Publications (1)

Publication Number Publication Date
CO2018007216A2 true CO2018007216A2 (es) 2018-09-20

Family

ID=57794352

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2018/0007216A CO2018007216A2 (es) 2015-12-15 2016-12-15 Ensayo de cuantificacion de peptido para diferenciar quininogeno de alto peso molecular (hmwk) de longitud completa y hmwk escindido

Country Status (13)

Country Link
US (3) US11668718B2 (enExample)
EP (2) EP3390439B1 (enExample)
JP (3) JP7092669B2 (enExample)
KR (2) KR102874711B1 (enExample)
CN (1) CN108602877A (enExample)
AU (3) AU2016372159B2 (enExample)
CA (1) CA3008621A1 (enExample)
CO (1) CO2018007216A2 (enExample)
EA (1) EA201891414A1 (enExample)
IL (4) IL297850B2 (enExample)
MX (2) MX2018007493A (enExample)
NZ (1) NZ743482A (enExample)
WO (1) WO2017106504A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3060908T (pt) 2013-10-21 2021-05-27 Dyax Corp Diagnóstico e tratamento de doenças autoimunes
KR20250066486A (ko) 2013-10-21 2025-05-13 다케다 파머수티컬 컴패니 리미티드 혈장 칼리크레인 시스템 바이오마커를 결정하기 위한 검정법
JP6903648B2 (ja) 2015-10-19 2021-07-14 ダイアックス コーポレーション 切断高分子量キニノーゲンを検出するイムノアッセイ
EP3390439B1 (en) 2015-12-15 2025-03-12 Takeda Pharmaceutical Company Limited Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk
WO2018225830A1 (ja) * 2017-06-08 2018-12-13 国立大学法人宮崎大学 肺がんの検出方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047323A (en) * 1986-01-22 1991-09-10 Temple University Of The Commonwealth System Of Higher Education Method for detecting human kininogen using monoclonal antibodies thereto
JP2603487B2 (ja) 1987-11-26 1997-04-23 大日本製薬株式会社 ガンに罹患している疑いのあるヒトをスクリーニングする方法
JPH08208692A (ja) 1994-09-28 1996-08-13 Sumitomo Pharmaceut Co Ltd 新規な細胞接着抑制ペプチド誘導体
JP3073439B2 (ja) * 1996-02-08 2000-08-07 雪印乳業株式会社 骨形成促進及び骨吸収防止剤
AU1521500A (en) 1998-11-10 2000-05-29 W. Robert Colman Inhibition of angiogenesis by peptide analogs of high molecular weight kininogendomain
US20060154319A1 (en) 1999-04-29 2006-07-13 Flodgaard Hans J Inhibition of bradykinin release
WO2001034195A1 (en) 1999-11-12 2001-05-17 Temple University Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5
CA2478962A1 (en) 2002-03-15 2003-09-25 Attenuon, Llc Cell surface tropomyosin as a target of angiogenesis inhibition
CN1858243A (zh) 2005-04-30 2006-11-08 安徽省生物医学研究所 一种预测血管紧张素ii受体拮抗剂类降压药药物作用的方法及其应用
EP2216651A4 (en) * 2007-10-18 2010-12-01 Miyazaki Prefectural Ind Suppo BIOMARKERS FOR THE DIAGNOSIS OF LIVER DISEASE
JP5348595B2 (ja) 2008-07-07 2013-11-20 日本臓器製薬株式会社 線維筋痛症の検査法
GB0821721D0 (en) 2008-11-27 2008-12-31 Hansa Medical Ab Antimicrobial therapy
DK3173792T3 (da) 2009-03-30 2019-08-05 Novartis Ag Crp neo-epitop fibrose-assay
JP5714285B2 (ja) 2010-09-29 2015-05-07 株式会社プロトセラ 妊娠高血圧症候群マーカーおよびそれを用いた診断
CN102558329A (zh) 2010-12-10 2012-07-11 中国人民解放军军事医学科学院生物医学分析中心 一组特异性多肽及其在制备肺癌早期诊断试剂中的用途
LT2831113T (lt) 2012-03-28 2018-06-25 Sanofi Antikūnai prieš bradikinino b1 receptoriaus ligandus
CN111044725B (zh) * 2013-01-20 2024-03-29 武田药品工业株式会社 缓激肽介导的病症的评估和治疗
JP2016188761A (ja) 2013-08-23 2016-11-04 国立研究開発法人国立国際医療研究センター 糖尿病腎症の発症または発症リスクの検出方法及びキット
KR20250066486A (ko) * 2013-10-21 2025-05-13 다케다 파머수티컬 컴패니 리미티드 혈장 칼리크레인 시스템 바이오마커를 결정하기 위한 검정법
WO2015120036A1 (en) * 2014-02-04 2015-08-13 University Of Virginia Patent Foundation Compositions and methods for analysis of protein sequences and post-translational modifications
CN104155457B (zh) 2014-08-22 2016-11-16 北京蛋白质组研究中心 一种结直肠癌相关“多肽-蛋白组合式标志物”检测试剂盒
CN104345154B (zh) 2014-08-22 2016-10-26 北京蛋白质组研究中心 一种检测多肿瘤相关“多肽-蛋白组合式标志物”的双抗体夹心试剂盒
WO2016081413A1 (en) * 2014-11-17 2016-05-26 The Rockefeller University Compositions and methods for use in diagnosis of alzheimer's disease
EP3390439B1 (en) 2015-12-15 2025-03-12 Takeda Pharmaceutical Company Limited Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk

Also Published As

Publication number Publication date
JP2024026847A (ja) 2024-02-28
US12135329B2 (en) 2024-11-05
JP7758766B2 (ja) 2025-10-22
IL297850B1 (en) 2024-06-01
US20210025898A1 (en) 2021-01-28
WO2017106504A8 (en) 2017-07-13
KR20240161708A (ko) 2024-11-12
MX2023000773A (es) 2023-02-22
JP7092669B2 (ja) 2022-06-28
US11668718B2 (en) 2023-06-06
MX2018007493A (es) 2018-09-18
EP4597115A2 (en) 2025-08-06
CN108602877A (zh) 2018-09-28
KR20180134838A (ko) 2018-12-19
US20250172567A1 (en) 2025-05-29
KR102874711B1 (ko) 2025-10-23
AU2016372159A1 (en) 2018-07-05
IL259995B2 (en) 2023-05-01
EA201891414A1 (ru) 2019-02-28
IL297850B2 (en) 2024-10-01
BR112018012165A2 (pt) 2018-12-04
KR102728491B1 (ko) 2024-11-13
AU2025200412A1 (en) 2025-02-13
AU2016372159B2 (en) 2022-03-24
EP4597115A3 (en) 2025-08-13
US20230408528A1 (en) 2023-12-21
AU2022204058B2 (en) 2024-10-31
JP2019505185A (ja) 2019-02-28
IL297850A (en) 2023-01-01
IL259995B1 (en) 2023-01-01
CA3008621A1 (en) 2017-06-22
NZ743482A (en) 2023-04-28
WO2017106504A1 (en) 2017-06-22
JP2022141640A (ja) 2022-09-29
EP3390439A1 (en) 2018-10-24
JP7425117B2 (ja) 2024-01-30
IL259995A (en) 2018-07-31
IL312919B1 (en) 2025-10-01
IL322971A (en) 2025-10-01
IL312919A (en) 2024-07-01
EP3390439B1 (en) 2025-03-12
AU2022204058A1 (en) 2022-06-30

Similar Documents

Publication Publication Date Title
CO2018007216A2 (es) Ensayo de cuantificacion de peptido para diferenciar quininogeno de alto peso molecular (hmwk) de longitud completa y hmwk escindido
MX2022007861A (es) Bibliotecas de polipeptidos modulares y metodos para elaborarlas y usarlas.
CR20110544A (es) Anticuerpo antagonista específico para el heterodímero de alfa-4-beta-7
EP3684512C0 (en) AUGMENTED REALITY DEVICES FOR HAZARDOUS CONTAMINANT TESTING
MX2021003549A (es) Anticuerpos dobles especificos.
BR112017010406A2 (pt) processo de realização de teste de alta produtividade de cromatografia líquida de alta eficiência
EA201792307A1 (ru) Способы репарации и регенерации тканей
DK3389682T3 (da) Gruppe b-adenovirus, der koder for et anti-tcr-kompleks-antistof eller -fragment
EP3442710C0 (en) KITS FOR STORING SAMPLE PROCESSING CONSUMABLES AND SAMPLE PROCESSING INSTRUMENTS
AR089934A1 (es) Analisis de datos de secuencias de adn
AR089559A1 (es) Construccion de listas de imagenes de referencia para codificar video
MX2017003790A (es) Detección de secuencias diana por percepción de nanoporos de sondas sintéticas.
EP4273263A3 (en) Systems and methods for determining nucleic acids
CL2015003608A1 (es) Evento transgénico de soja mon87751 y métodos para su detección y uso.
BR112015001592A8 (pt) análise de imagem e medidas de amostras biológicas
BR112016008970A2 (pt) Método de ativação ex vivo e para avaliar ativação plasmática em um indivíduo, ensaio ex vivo para determinar atividade de calicreína plasmática em uma amostra
EA201592263A1 (ru) Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
MX2020002977A (es) Agonistas de receptor de peptido similar al glucagon tipo 1 y usos de los mismos.
BR112017019919A2 (pt) sondas ópticas para metaloproteinases de matriz
UY37576A (es) Anticuerpos dirigidos a hueso
CA2968488C (en) Method for detecting binding interactions
MX2016011394A (es) Moleculas de andamiaje a base de fibronectina estabilizada.
BR112016022829A8 (pt) Dispositivo de teste para determinar a presença de um primeiro ligante em uma amostra líquida e método para testar uma amostra quanto à presença de um primeiro ligante
MX2017008096A (es) Pestivirus.
IL289749A (en) Assay apparatuses, methods and reagents